(1)
Achievement of No-to-Minimal Itch and Sleep Improvement With Tapinarof Cream 1% Once Daily in Two Pivotal Phase 3 Trials in Adults and Children Down to 2 Years of Age With Atopic Dermatitis. J of Skin 2024, 8 (6), s459. https://doi.org/10.25251/skin.8.supp.459.